Rubric Capital Management (New York)’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $39.1M | Buy |
|
|||||
|
2025
Q3 | $36.7M | Buy |
|
|||||
|
2025
Q2 | $55.3M | Hold |
|
|||||
|
2025
Q1 | $58.8M | Hold |
|
|||||
|
2024
Q4 | $40.9M | Hold |
|
|||||
|
2024
Q3 | $53.2M | Hold |
|
|||||
|
2024
Q2 | $93.5M | Hold |
|
|||||
|
2024
Q1 | $74M | Hold |
|
|||||
|
2023
Q4 | $45.4M | Hold |
|
|||||
|
2023
Q3 | $27.5M | Buy |
|
|||||
|
2023
Q2 | $13.6M | Hold |
|
|||||
|
2023
Q1 | $17.7M | Hold |
|
|||||
|
2022
Q4 | $29.4M | Buy |
|
|||||
|
2022
Q3 | $10.6M | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $36.7M | Sell |
|
|||||
|
2018
Q4 | $72.3M | Buy |
|
|||||
|
2018
Q3 | $62M | Buy |
|
|||||
|
2018
Q2 | $44.3M | Sell |
|
|||||
|
2018
Q1 | $41.7M | Sell |
|
|||||
|
2017
Q4 | $39.8M | Buy |
|
|||||
|
2017
Q3 | $30.7M | Buy |
|
|||||
|
2017
Q2 | $23.5M | Buy |
|
|||||
|
2017
Q1 | $24M | Buy |
|
|||||
|
2016
Q4 | $7.21M | Buy |
|